Evidence map›Paper›PMID 34395414›Full record

ArticleFrontiers in cell and developmental biology2021

KIT Is Required for Fetal Liver Hematopoiesis.

Alessandro Fantin, Carlotta Tacconi, Emanuela Villa, Elena Ceccacci, Laura Denti, Christiana Ruhrberg

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The evolving hematopoietic niche during development.Frontiers in molecular biosciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Alessandro FantinUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Carlotta TacconiDepartment of Biosciences, University of Milan, Milan, Italy.
Emanuela VillaDepartment of Biosciences, University of Milan, Milan, Italy.
Elena CeccacciDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Laura DentiUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Christiana RuhrbergUCL Institute of Ophthalmology, University College London, London, United Kingdom.
University of Milan · ITUniversity College London · GBEuropean Institute of Oncology · IT

Funding

Wellcome Trust 205099/Z/16/Z
6 · The paper itself

Abstract

In the mouse embryo, endothelial cell (EC) progenitors almost concomitantly give rise to the first blood vessels in the yolk sac and the large vessels of the embryo proper. Although the first blood cells form in the yolk sac before blood vessels have assembled, consecutive waves of hematopoietic progenitors subsequently bud from hemogenic endothelium located within the wall of yolk sac and large intraembryonic vessels in a process termed endothelial-to-hematopoietic transition (endoHT). The receptor tyrosine kinase KIT is required for late embryonic erythropoiesis, but KIT is also expressed in hematopoietic progenitors that arise via endoHT from yolk sac hemogenic endothelium to generate early, transient hematopoietic waves. However, it remains unclear whether KIT has essential roles in early hematopoiesis. Here, we have combined single-cell expression studies with the analysis of knockout mice to show that KIT is dispensable for yolk sac endoHT but required for transient definitive hematopoiesis in the fetal liver.

Indexed as

erythromyeloid progenitorsfetal liverhemogenic endotheliumKITyolk sac

Identifiers

PMID34395414
PMCPMC8358609
OpenAlexW3187410177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.